Vivo Infusion announced on January 31 it has acquired Wilton, Connecticut-based CIVIC Infusion.
Vivo Infusion will now have a combined 36 ambulatory infusion centers across nine states. CIVIC’s co-founders Barry D. Stein, M.D. and Robert M. Roteman, M.D. will join Vivo Infusion as medical directors. Financial terms of the transaction were not disclosed.
Founded in 2018, CIVIC Infusion delivers solutions for infusion patients in Connecticut and New York. It offers therapies for acute and chronic conditions in specialties such as allergy/immunology, gastroenterology, neurology and rheumatology. CIVIC’s physicians work with certified infusion nurses to provide medical care to adult and pediatric patients.
Based in Lakewood, Colorado, Vivo Infusion is a provider of infusion and injection care for patients suffering from compromised immune systems, infectious diseases and other medical conditions. Vivo serves communities in Colorado, Florida, Ohio, Oklahoma, Pennsylvania, New Jersey and Texas with plans to expand into additional states. Private equity firm InTandem Capital Partners created Vivo Infusion by merging MPP Infusion Centers and ID Consultants in March 2022.
According to data captured in the LevinPro HC database, this acquisition marks the first infusion services transaction of 2023. Throughout 2022, there were 30 infusion services transactions announced.
